Issue: March 25, 2016

March 25, 2016

1 min read

Save

This article is more than 5 years old. Information may no longer be current.

Myeloproliferative Neoplasms and Myelodysplastic Syndrome Drugs in the Pipeline

Issue: March 25, 2016

HemOnc Today presents this guide to drugs in phase 2 or phase 3 development for myeloproliferative neoplasms and myelodysplastic syndrome. Clinicians can use this chart as a quick reference to learn about the status of those drugs that may be clinically significant to their practice.

Information in this chart was compiled from the Pharmaceutical Research and Manufacturers of America, NIH (www.clinicaltrials.gov), corporate websites and the databases of HemOnc Today. The publisher or editors do not assume responsibility for any errors or omissions.